CAV1 and ductal breast carcinoma in situ: More specifically, it was shown that loss of stromal CAV1 expression accelerates the progression of ductal carcinoma in situ to invasive cancer and is associated with more advanced disease with higher T and N stages, higher recurrence rates, and decreased DFS and OS8, 9, 17–21.